Patent: 9,205,046
✉ Email this page to a colleague
Summary for Patent: 9,205,046
| Title: | Enhanced stability of inverse thermal gelling composite hydrogels |
| Abstract: | The present invention relates to a composite hydrogel comprising a blend of an aqueous solution of an anionic polysaccharide or a derivative thereof, such as hyaluronan (also commonly referred to as hyaluronic acid) or a derivative thereof and an aqueous solution of methylcellulose or another water soluble cellulose derivative thereof, having dispersed polymeric particles, such as polymeric hydrophobic particles therein selected from micro particles and nanoparticles, and wherein the stability of the hydrogel is enhanced relative to the stability of the hydrogel alone. The polymeric particles may contain at least one therapeutic agent, in which case each therapeutic agent exhibits a linear sustained release rate that can be tuned or altered by selecting the appropriate polymer formulation of the micro particles and/or nanoparticles. The composite may be injectable, and in the absence of a therapeutic agent may be used as a bulking agent for reconstructive and cosmetic surgery or may act as a platform for subsequent delivery of therapeutic agents. |
| Inventor(s): | Shoichet; Molly S. (Toronto, CA), Baumann; M. Douglas (St. Catharines, CA), Kang; Catherine Elizabeth (Chicago, IL) |
| Assignee: | The Governing Council of the University of Toronto (Toronto, Ontario, CA) |
| Application Number: | 12/778,879 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,205,046
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Emd Serono, Inc. | PERGONAL | menotropins | For Injection | 017646 | 08/22/1975 | ⤷ Try a Trial | 2025-04-25 |
| Emd Serono, Inc. | PERGONAL | menotropins | For Injection | 017646 | 05/20/1985 | ⤷ Try a Trial | 2025-04-25 |
| Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | HUMEGON | menotropins | For Injection | 020328 | 09/01/1994 | ⤷ Try a Trial | 2025-04-25 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
